This trial is unknown!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Ischemic Heart Failure
and you are
between 40 and 75
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

The main purpose of this research is to reveal the curative effect mechanism of Yiqihuoxue prescription which treat the disease of qi deficiency and blood stasis. And at the same time this study also try to confirm yiqi huoxue fang qi deficiency blood stasis treatment of coronary heart disease (CHD) heart failure the curative effect and security.

Provided treatments

  • Drug: Yiqi prescription
  • Drug: Huoxue prescription
  • Drug: Buyang huanwu decoction
  • Drug: Placebo 1
  • Drug: Placebo 2

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02875639. The sponsor of the trial is Zhu Mingjun and it is looking for 180 volunteers for the current phase.
Official trial title: